| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 02/15/2007 | US20070036818 Fabricated in baculovirus; for penetration into human erythrocytes in event of infection; vaccines against malaria |
| 02/15/2007 | US20070036814 Antibody binding to polypeptide of given sequence; antisera; use in wound healing, blocking adherence to indwelling medical devices, vaccines |
| 02/15/2007 | US20070036813 Expression vector comprising nucleotide sequences coding endothelial growth factor protein for use in prevention and treatment of cell proliferative and eye disorders |
| 02/15/2007 | US20070036812 polypeptide with binding to antigen and is recognized by cytotoxic T lymphocytes; use as cancer vaccine |
| 02/15/2007 | US20070036810 Cyclic amp response element activator proteins and uses related thereto |
| 02/15/2007 | US20070036809 Tolerance-induced targeted antibody production |
| 02/15/2007 | US20070036799 Identification and engineering of antibodies with variant Fc regions and methods of using same |
| 02/15/2007 | US20070036796 For treating immunosuppressive diseases; AIDS |
| 02/15/2007 | US20070036794 Agonist anti-trkC monoclonal antibodies, directed against epitopes in extracellular domain of trkC receptor, which mimic biological activities of NT-3, the natural ligand of trkC receptor, but are free of some of known detriments of NT-3; use of theseagonist antibodies treatment of neuropathy |
| 02/15/2007 | US20070036793 Methods for use of an lkb1/strad7mo25 complex |
| 02/15/2007 | US20070036789 Neutralizable Epitope of HGF and Neutralizing Antibody Binding to the Same |
| 02/15/2007 | US20070036788 Use of a compound for reducing the biological effectiveness of il-6 |
| 02/15/2007 | US20070036784 Medicament for the protection against thrombotic diseases |
| 02/15/2007 | US20070036782 Apo-2 ligand |
| 02/15/2007 | US20070036780 Modified proteins, designer toxins, and methods of making thereof |
| 02/15/2007 | US20070036778 Staphylococcus; immunogens; immumostimulatory sequences; cationic peptides |
| 02/15/2007 | US20070036763 Interleukin-17 receptor homologue |
| 02/15/2007 | US20070036752 IL-2 fusion proteins with modulated selectivity |
| 02/15/2007 | US20070036750 MCP1 fusions |
| 02/15/2007 | US20070036734 Therapeutic agent for periodontal disease |
| 02/15/2007 | US20070036719 antibodies and their use for detecting, imaging, staging, treating and monitoring of prostate cancer, and/or metastasis; prostate specific membrane antigen (PSMA) |
| 02/15/2007 | CA2618796A1 Tcr-v-beta related peptides for treatment and diagnosis of autoimmune disease |
| 02/15/2007 | CA2615776A1 Secretion of antibodies without signal peptides from bacteria |
| 02/15/2007 | CA2615460A1 Antibody compositions, methods for treating neoplastic disease and methods for regulating fertility |
| 02/14/2007 | EP1752538A1 Human bikunin |
| 02/14/2007 | EP1752525A1 Amylase variants |
| 02/14/2007 | EP1752472A2 Chimeric amyloid beta peptides |
| 02/14/2007 | EP1752465A2 Linear VH-CH1-VH-CH1 heavy chain antibody fragment |
| 02/14/2007 | EP1752160A2 Epitope sequences |
| 02/14/2007 | EP1751312A2 Polymorphism in tryptophan hydroxylase-2 controls brain serotonin synthesis |
| 02/14/2007 | EP1751301A2 Endothelial cell apoptosis induced by fibrinogen gamma chain c-terminal fragment |
| 02/14/2007 | EP1751300A2 T-cell death-inducing epitopes |
| 02/14/2007 | EP1751299A2 Methods for evaluating ribonucleotide sequences |
| 02/14/2007 | EP1751289A1 Tc-83-derived alphavirus vectors, particles and methods |
| 02/14/2007 | EP1751284A2 Method and compositions for detecting botulinum neurotoxin |
| 02/14/2007 | EP1751282A2 Production of host cells containing mutiple integrating vectors by serial transduction |
| 02/14/2007 | EP1751279A2 Nucleic acids and polypeptides involved in the production of cryptophycin |
| 02/14/2007 | EP1750774A2 Composition and method of cancer treatment |
| 02/14/2007 | EP1750737A2 Improved method for identifying peptides in a biological sample |
| 02/14/2007 | EP1360283B1 Expression of recombinant proteinase k from tritirachium album in yeast |
| 02/14/2007 | EP1347048B1 Novel protease |
| 02/14/2007 | EP1341790B1 Sulfonamido ether substituted imidazoquinolines |
| 02/14/2007 | EP1283214B1 Novel collectins |
| 02/14/2007 | EP1206495B1 Chimeric polypeptides, method for production and uses thereof |
| 02/14/2007 | EP1044983B1 Antibiotic tkr2999, process for the preparation thereof and microbe |
| 02/14/2007 | EP1035780B1 Method for purifying heat shock peptides complexes |
| 02/14/2007 | EP1034268B1 G-protein coupled receptors and uses therefor |
| 02/14/2007 | EP0815200B1 Host cell expressing reduced levels of a metalloprotease and methods using the host cell in protein production |
| 02/14/2007 | EP0770136B1 Method for selecting high-expressing host cells |
| 02/14/2007 | EP0662077B1 Cd27 ligand |
| 02/14/2007 | CN1914322A Cell expansion lethal toxin and detection of bacterium belonging to campylobacter genus that targets the same |
| 02/14/2007 | CN1914320A Expression system with the use of mammalian beta -actin promoter |
| 02/14/2007 | CN1914318A Method of obtaining gene tag |
| 02/14/2007 | CN1914223A Modified human interferon polypeptides and their uses |
| 02/14/2007 | CN1912127A Colibacillus expression carrier and its application |
| 02/14/2007 | CN1912119A Human HS5 AR-iso gene sequence, its coded protein and preparation method |
| 02/14/2007 | CN1912113A Protein and nuclein of antrodia camphoratu antioxidase and preparation method and use thereof |
| 02/14/2007 | CN1912111A Engomphosis and radiolabeled antibodies to human b lymphocyte restricted differentiation antigen |
| 02/14/2007 | CN1911965A Binding domain-immunoglobulin fusion proteins |
| 02/14/2007 | CN1300328C Protein hydrol ysater enriched in peptides having a carboxy termina proline residue |
| 02/14/2007 | CN1300327C Process for preparing peptidoglycan |
| 02/14/2007 | CN1300320C Alzhimer's disease secretase |
| 02/14/2007 | CN1300318C DNA which code Mycoplasma mycoides subspecies N terminal lipoprotein |
| 02/14/2007 | CN1300317C Anti-listeria bacteriocin |
| 02/14/2007 | CN1300303C Method for preparing protein of visual purple and dedicated strain |
| 02/14/2007 | CN1300173C Human antibodies that bind huma TNF 'alpha' |
| 02/14/2007 | CN1300170C Novel DnaJ/Hsp40 molecule DC-DJIII, its coding sequence and application |
| 02/14/2007 | CN1299767C Production of fowl leukocyte interferon |
| 02/13/2007 | US7176294 Transcription factor, BP1 |
| 02/13/2007 | US7176290 Tau protein epitopes for use in the treatment of alzheimer's disease |
| 02/13/2007 | US7176289 Monoclonal antibody or fragment which binds to an eight amino acid epitope of the sequence glutamine-serine-arginine-aspartic acid-threonine-glutamic acid-valine-leucine present within amino acids 175 536 of SEQ ID NO: 4 in a diluent or excipient; modulator screening; antitumor and -carcinogenic agents |
| 02/13/2007 | US7176283 Protease-activated receptor 3 and uses thereof |
| 02/13/2007 | US7176185 A di, tri or oligopeptide covalently bonded with an active agent ( therapeutical agent, contrast agent or fluorescent dye) from a side chain of the intermediate or C-terminus amino acid |
| 02/13/2007 | US7176180 Fusion proteins; immunoglobulins; kits |
| 02/13/2007 | US7176178 Protein H and its fragments/derivatives are capable of interacting with nucleophosmin/B23, actin, NPM/B23, protein SET or hnRNP A2/B1 |
| 02/13/2007 | US7176027 Genes and regulatory DNA sequences associated with stress-related gene expression in plants and methods of using the same |
| 02/13/2007 | US7176020 Detection and monitoring anticarcinogenic agents; obtain tissue, infect with cancer cells, incubate with test compound, monitor antiproliferative activity |
| 02/13/2007 | US7176010 Encoded amino acid sequences, DNAs encoding the proteins, recombinant vectors, culturing, drugs comprising the proteins or DNAs, antibodies, drug screening, for arteriosclerosis, hyperlipidemia, obesity or mellitus diabetes |
| 02/13/2007 | US7176009 Sucrose phosphate synthase |
| 02/13/2007 | US7176001 Manufacture and purification of cyclosporin A |
| 02/13/2007 | US7175997 BMP-11 compositions |
| 02/13/2007 | US7175996 Methods of optimizing antibody variable region binding affinity |
| 02/13/2007 | US7175995 Use of nucleotide sequences of TCL-1 genes and amino acid sequences of their encoded TCL-1 proteins as diagnostic reagents or in the preparation of diagnostic agents useful in the detection of disease states, such as T-cell leukemias, associated with chromosomal abnormalities |
| 02/13/2007 | US7175983 Adapter-directed display systems |
| 02/13/2007 | US7175849 Polypeptide for use in the treatment of viral disorders |
| 02/13/2007 | US7175846 Cancerous disease modifying antibodies |
| 02/13/2007 | CA2298400C .beta.-fructofuranosidase gene |
| 02/13/2007 | CA2219947C Monoclonal antibody reactive to human cetp and assay method for human cetp |
| 02/13/2007 | CA2177959C Homologous recombination antibody expression system for murine cells |
| 02/13/2007 | CA2165781C Process for producing relaxin |
| 02/13/2007 | CA2124958C Inhibitory immunoglobulin polypeptides to human pdgf beta receptor |
| 02/08/2007 | WO2007016257A2 Method for evaluating drug candidates |
| 02/08/2007 | WO2007016221A2 Hyaluronan synthases and methods of making and using same |
| 02/08/2007 | WO2007015848A2 Improved methods and compositions for increasing longevity and protein yield from a cell culture |
| 02/08/2007 | WO2007015771A2 Composition and method for introduction of rna interference sequences into targeted cells and tissues |
| 02/08/2007 | WO2007015527A1 tRNA SYNTHESIS METHOD, NUCLEIC ACID, AMINOACYL tRNA SYNTHESIS METHOD, AND PROCESS FOR PRODUCTION OF PROTEIN HAVING NON-NATURAL AMINO ACID INTEGRATED THEREIN |
| 02/08/2007 | WO2007015470A1 Yeast host, transformant and method of producing foreign protein |
| 02/08/2007 | WO2007014459A1 Cancerous disease modifying antibodies |
| 02/08/2007 | WO2007014458A1 Cancerous disease modifying antibodies |
| 02/08/2007 | WO2007014457A1 Cancerous disease modifying antibodies |